164 related articles for article (PubMed ID: 32507380)
1. Antipsychotic medications and the progression of upper respiratory infection to pneumonia in patients with schizophrenia.
Chang CK; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ
Schizophr Res; 2020 Aug; 222():327-334. PubMed ID: 32507380
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study.
Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ
J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study.
Rohde C; Siskind D; de Leon J; Nielsen J
Acta Psychiatr Scand; 2020 Aug; 142(2):78-86. PubMed ID: 31875941
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia.
Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ
Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915
[TBL] [Abstract][Full Text] [Related]
5. Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine: A Nationwide Cohort Study.
Wu CS; Chen TY; Tsai SY; Chen CC; Kuo CJ
J Clin Psychopharmacol; 2019; 39(4):297-304. PubMed ID: 31188233
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
7. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
[TBL] [Abstract][Full Text] [Related]
8. Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital.
Kang N; Kim SH; Kim J; Kim S; Jang J; Yoon H; Lee J; Kim M; Kim YS; Kwon JS
Schizophr Res; 2024 Jun; 268():107-113. PubMed ID: 37770376
[TBL] [Abstract][Full Text] [Related]
9. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
[TBL] [Abstract][Full Text] [Related]
10. Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.
Lähteenvuo M; Luykx JJ; Taipale H; Mittendorfer-Rutz E; Tanskanen A; Batalla A; Tiihonen J
Br J Psychiatry; 2022 Dec; 221(6):758-765. PubMed ID: 36004532
[TBL] [Abstract][Full Text] [Related]
11. An update on the complex relationship between clozapine and pneumonia.
Schoretsanitis G; Ruan CJ; Rohde C; Verdoux H; De Las Cuevas C; Spina E; de Leon J
Expert Rev Clin Pharmacol; 2021 Feb; 14(2):145-149. PubMed ID: 33461363
[No Abstract] [Full Text] [Related]
12. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
[TBL] [Abstract][Full Text] [Related]
13. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.
Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H
Br J Psychiatry; 2020 Sep; 217(3):498-505. PubMed ID: 31910911
[TBL] [Abstract][Full Text] [Related]
14. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
Wu CS; Wang SC; Yeh IJ; Liu SK
J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of death compared to other antipsychotics in elderly clozapine users in Poland.
Zagożdzon P; Waszak P
Int Clin Psychopharmacol; 2022 May; 37(3):110-115. PubMed ID: 35258033
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study.
Joo SW; Kim H; Jo YT; Ahn S; Choi YJ; Choi W; Park S; Lee J
Eur Neuropsychopharmacol; 2022 Jun; 59():36-44. PubMed ID: 35550204
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.
Taipale H; Mehtälä J; Tanskanen A; Tiihonen J
Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458
[TBL] [Abstract][Full Text] [Related]
18. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
19. Clozapine usage increases the incidence of pneumonia compared with risperidone and the general population: a retrospective comparison of clozapine, risperidone, and the general population in a single hospital over 25 months.
Stoecker ZR; George WT; O'Brien JB; Jancik J; Colon E; Rasimas JJ
Int Clin Psychopharmacol; 2017 May; 32(3):155-160. PubMed ID: 28059928
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan.
Chen WY; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ
Schizophr Res; 2024 Jun; 268():150-160. PubMed ID: 37479588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
